Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

XRP (CRYPTO: XRP) is testing a make-or-break support level as traders debate whether $1.90 holds or the price drops toward $1.80. After weeks of selling pressure and thin liquidity, the XRP price has ...

Attention! Another new term has entered the TikTok lexicon, and you’re about to see it everywhere. If you’ve spent any time on the app within the past week, you might have noticed people talking about ...

When a legacy scrub is started on a pool that is later exported and re-imported, if the system setting has changed back to sequential as the default, the scrub will resume as a sequential scrub rather ...

Q3 Adjusted EBITDA of $6.2M, up 45% sequentially Q3 Adjusted EBITDA Margin of 42%, up 12 percentage points from Q2 Q3 Free Cash Flow of $5.9M, up 56% sequentially with 94% conversion Unless otherwise ...

Dow's third-quarter results reflected a continued cyclical bottom amid weak end-market demand as sales declined across all segments versus the prior-year quarter. Yet, Dow shares rallied 12% at the ...

Plexus projects fiscal Q4 revenue between $1.025 billion and $1.065 billion, non-GAAP operating margin of 5.7% to 6.1%, and non-GAAP EPS of $1.82 to $1.97. Kelsey said, “At the midpoint, our fiscal ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. For decades, preservationists charged with digitizing rare books ...

Bees’ remarkable visual learning abilities make them ideal for studying active information acquisition and representation. Here, we develop a biologically inspired model to examine how flight ...